Bio-Connect

SARS-CoV-2 (COVID-19) Nucleocapsid antibody

GTX135361
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityVirus
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    SARS-CoV-2 (COVID-19) Nucleocapsid antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:1000-1:10000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Host
    Rabbit
  • Isotype
    IgG
  • Reactivity
    Virus
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • de Melo GD, Perraud V, Alvarez F, et al. Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants. Nat Commun. 2023,14(1):4485. doi: 10.1038/s41467-023-40228-7
    Read this paper
  • Margaroli C, Fram T, Sharma NS, et al. Type I interferon-dependent IFIT3 signaling is critical for viral clearance in airway neutrophils. Res Sq. 2023,:pii: rs.3.rs-1812836. doi: 10.21203/rs.3.rs-1812836/v1.
    Read this paper
  • Margaroli C, Benson P, Gastanadui MG, et al. Spatial transcriptomic profiling of coronary endothelial cells in SARS-CoV-2 myocarditis. Front Med (Lausanne). 2023,10:1118024. doi: 10.3389/fmed.2023.1118024
    Read this paper
  • Yang J, Xiao Y, Lidsky PV, et al. Fluorogenic reporter enables identification of compounds that inhibit SARS-CoV-2. Nat Microbiol. 2023,8(1):121-134. doi: 10.1038/s41564-022-01288-5
    Read this paper
  • Wu CT, Lidsky PV, Xiao Y, et al. SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming. Cell. 2023,186(1):112-130.e20. doi: 10.1016/j.cell.2022.11.030
    Read this paper
  • Niemeyer D, Stenzel S, Veith T, et al. SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression. PLoS Biol. 2022,20(11):e3001871. doi: 10.1371/journal.pbio.3001871
    Read this paper
  • Besselink G, Schütz-Trilling A, Veerbeek J, et al. Asymmetric Mach-Zehnder Interferometric Biosensing for Quantitative and Sensitive Multiplex Detection of Anti-SARS-CoV-2 Antibodies in Human Plasma. Biosensors (Basel). 2022,12(8). doi: 10.3390/bios12080553
    Read this paper
  • Pipolo C, Bottai D, Fuccillo E, et al. Evidence of SARS-CoV-2 in nasal brushings and olfactory mucosa biopsies of COVID-19 patients. PLoS One. 2022,17(4):e0266740. doi: 10.1371/journal.pone.0266740
    Read this paper
  • Burkett AE, Sher SB, Patel CR, et al. Gastrointestinal Manifestations of COVID-19 Infection: Clinicopathologic Findings in Intestinal Resections Performed at Single Institution. Front Med (Lausanne). 2022,9:811546. doi: 10.3389/fmed.2022.811546
    Read this paper
  • Kaufmann E, Khan N, Tran KA, et al. BCG vaccination provides protection against IAV but not SARS-CoV-2. Cell Rep. 2022,38(10):110502. doi: 10.1016/j.celrep.2022.110502
    Read this paper